Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 16/20 | 0.68 |
| ▸ | ADRB3 | P13945 | 15/20 | 0.68 |
| ▸ | ADRB2 | P07550 | 7/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6540206 | 1.00 | ADRB1 (0.68) | ADRB1ADRB3ADRB2GLACYP2C9 | |
| SCHEMBL6541487 | 0.90 | ADRB3 (0.81) | ADRB1ADRB3ADRB2CYP2C9NAMPT | |
| SCHEMBL6541481 | 0.90 | ADRB1 (0.68) | ADRB1ADRB3ADRB2CYP2C9NAMPT | |
| SCHEMBL6553044 | 0.83 | ADRB2 (0.64) | ADRB1ADRB3ADRB2 | |
| SCHEMBL6553047 | 0.83 | ADRB2 (0.64) | ADRB1ADRB3ADRB2 | |
| SCHEMBL6541336 | 0.82 | ADRB3 (0.52) | ADRB1ADRB3ADRB2GLACYP2C9 | |
| SCHEMBL6541342 | 0.82 | ADRB3 (0.52) | ADRB1ADRB3ADRB2GLACYP2C9 | |
| Hydrochloric Acid SCHEMBL4472423 | 0.81 | ADRB3 (0.98) | ADRB1ADRB3ADRB2 | |
| Hydrochloric Acid SCHEMBL4472428 | 0.81 | ADRB3 (0.98) | ADRB1ADRB3ADRB2 | |
| SCHEMBL7153666 | 0.80 | ADRB3 (0.77) | ADRB1ADRB3ADRB2GLACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040138462-A1 | Aminoalcohol derivatives | ASTELLAS PHARMA INC. (JP) | 2004-07-15 | — | — | US | disclosed |
| EP-1389185-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-02-18 | — | — | EP | disclosed |
| WO-2002094770-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138462-A1 | Aminoalcohol derivatives | BPHL, FANCD2, HRH2 | ADRB1 7/4885ADRB3 58/4885ADRB2 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.